ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MREO Mereo BioPharma Group PLC

2.74
-0.07 (-2.49%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Mereo BioPharma Group PLC MREO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.07 -2.49% 2.74 07:32:57
Open Price Low Price High Price Close Price Previous Close
2.81 2.73 2.81 2.74 2.81
more quote information »

Recent News

Date Time Source Heading
03/4/202422:30GLOBEMereo BioPharma to Participate in Fireside Chat at the 23rd..
28/3/202407:01GLOBEMereo BioPharma Reports Full Year 2023 Financial Results and..
05/3/202423:30GLOBEMereo BioPharma to Participate in Fireside Chat at the..
10/2/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202408:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202408:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202423:08EDGAR2Form 8-K - Current report
08/1/202423:00GLOBEMereo BioPharma Provides Update on Pipeline Progress and..
03/1/202408:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202408:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202408:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202408:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202408:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202408:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202408:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/12/202308:16EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
19/12/202308:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/202308:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202323:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202307:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202307:01GLOBEMereo BioPharma Reports on Recent Program Developments and..
17/10/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/10/202307:30GLOBEUltragenyx and Mereo BioPharma Announce Interim Phase 2 Data..
09/10/202323:00GLOBEUltragenyx to Present Setrusumab (UX143) Update at ASBMR..
21/9/202321:00GLOBEMereo BioPharma to Participate in Fireside Chat at the 2023..
21/9/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/9/202321:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/9/202321:30GLOBEMereo BioPharma Reports Interim Financial Results for the..
27/7/202306:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/7/202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/7/202322:00GLOBEUltragenyx Announces First Patients Dosed in Phase 3 Program..
01/7/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202321:00GLOBEMereo BioPharma to Present at the Jefferies Healthcare..
24/5/202303:43GLOBEPhase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s..
09/5/202302:46GLOBEMereo BioPharma Regains Compliance with Nasdaq Minimum Bid..
06/5/202306:06GLOBEMereo BioPharma Announces Listing Transfer to Nasdaq Capital..

Your Recent History

Delayed Upgrade Clock